Low mortality in vaccinated immunocompromised haematology patients infected with <scp>SARS‐CoV</scp> ‐2-Reference-Cited by-同舟云学术

Low mortality in vaccinated immunocompromised haematology patients infected with SARS‐CoV ‐2

Published:2022-11-27 Issue:12 Volume:52 Page:2172-2175
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Shaw Briony¹²^ORCID,Shortt Jake¹²,Low Michael¹²,Rogers Benjamin¹³,Kaplan Zane¹²,Fedele Pasquale¹²,Gregory Gareth¹²^ORCID,Vilcassim Shahla¹²,Gilbertson Michael¹²,Grigoriadis George¹²,Opat Stephen¹²

Affiliation:

1. Department of Clinical Haematology Monash Health Melbourne Victoria Australia

2. Monash University Melbourne Victoria Australia

3. Department of Infectious Diseases Monash Health Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.15954

Reference17 articles.

1. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

2. Factors associated with COVID-19-related death using OpenSAFELY

3. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

4. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

5. Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. High prevalence of persistent COVID‐19‐related health anxiety and social restriction in patients with haematological disorders;British Journal of Haematology;2023-07-05

3. SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?;Hemato;2023-05-26

4. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients;Frontiers in Immunology;2023-03-31

5. High risk of infection in ‘real‐world’ patients receiving ibrutinib, idelalisib or venetoclax for mature B‐cell leukaemia/lymphoma;European Journal of Haematology;2023-02-15